Pharsight

Hq Spclt Pharma patents expiration

1. Calcium Gluconate In Sodium Chloride patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10342813 HQ SPCLT PHARMA Calcium gluconate solutions in flexible containers
Jul, 2037

(13 years from now)

US10130646 HQ SPCLT PHARMA Calcium gluconate solutions in flexible containers
Jul, 2037

(13 years from now)

Drugs and Companies using CALCIUM GLUCONATE ingredient

Market Authorisation Date: 29 October, 2018

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

CALCIUM GLUCONATE IN SODIUM CHLORIDE family patents

Family Patents

2. Dexmedetomidine Hydrochloride patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9649296 HQ SPCLT PHARMA Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
Apr, 2036

(12 years from now)

US9717796 HQ SPCLT PHARMA Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
Apr, 2036

(12 years from now)

Drugs and Companies using DEXMEDETOMIDINE HYDROCHLORIDE ingredient

Market Authorisation Date: 21 October, 2015

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

DEXMEDETOMIDINE HYDROCHLORIDE family patents

Family Patents

3. Esmolol Hydrochloride Double Strength In Plastic Container patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8835505 HQ SPCLT PHARMA Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
Mar, 2033

(9 years from now)

US8829054 HQ SPCLT PHARMA Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
Mar, 2033

(9 years from now)

Drugs and Companies using ESMOLOL HYDROCHLORIDE ingredient

Market Authorisation Date: 07 April, 2016

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic